BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22747970)

  • 1. Possibility of sandwiched liver surgery with molecular targeting drugs, cetuximab and bevacizumab on colon cancer liver metastases: a case report.
    Toyama Y; Ushigome T; Watanabe K; Kitamura H; Onda S; Saito R; Yoshida S; Kawahara H; Yanagisawa S; Yanaga K
    World J Surg Oncol; 2012 Jun; 10():129. PubMed ID: 22747970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of multiple lung and liver metastases from colon cancer treated with clinical benefit by hepatic arterial infusion chemotherapy plus cetuximab mono-therapy after standard chemotherapy failure].
    Osawa G; Yoshimatsu K; Yokomizo H; Otani T; Yano Y; Itagaki H; Matsumoto A; Fujimoto T; Umehara A; Ogawa K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2526-8. PubMed ID: 21224628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.
    Folprecht G; Gruenberger T; Bechstein WO; Raab HR; Lordick F; Hartmann JT; Lang H; Frilling A; Stoehlmacher J; Weitz J; Konopke R; Stroszczynski C; Liersch T; Ockert D; Herrmann T; Goekkurt E; Parisi F; Köhne CH
    Lancet Oncol; 2010 Jan; 11(1):38-47. PubMed ID: 19942479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cetuximab plus chronomodulated irinotecan, 5-fluorouracil, leucovorin and oxaliplatin as neoadjuvant chemotherapy in colorectal liver metastases: POCHER trial.
    Garufi C; Torsello A; Tumolo S; Ettorre GM; Zeuli M; Campanella C; Vennarecci G; Mottolese M; Sperduti I; Cognetti F
    Br J Cancer; 2010 Nov; 103(10):1542-7. PubMed ID: 20959822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A case of sigmoid colon cancer with synchronous multiple liver and lung metastases, who survived 25-month after combination of chemotherapy and metastasectomy].
    Kikuchi A; Ishikawa T; Uetake H; Tanaka S; Arii S; Sugihara K
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2539-41. PubMed ID: 21224632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of liver metastasis of rectal cancer, refractory to previous chemotherapy(5-FU/LV, irinotecan, oxaliplatin) responding to bevacizumab combined with FOLFIRI chemotherapy].
    Nishigami K; Kawami H; Yamaguchi T; Yamaguchi K; Kato S
    Gan To Kagaku Ryoho; 2009 Oct; 36(10):1765-8. PubMed ID: 19838045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of sigmoid colon cancer with lymphangitis carcinomatosa successfully treated with chemotherapies including molecular targeting drugs].
    Sogabe S; Yuki S; Takagi T; Miyazaki T; Takano H; Kawamoto Y; Nakatsumi H; Sasaki T; Iwanaga I; Uehata Y; Asaka M; Komatsu Y
    Gan To Kagaku Ryoho; 2010 Mar; 37(3):535-8. PubMed ID: 20332699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One patient with metastastic colorectal cancer successfully treated by combination of targeted agents after failure of chemotherapy.
    Xia LP; Wu PH; Xia JC; Zhang B; Guan ZZ; Wan DS; Guo GF; Zeng YX
    Chin J Cancer; 2010 Dec; 29(12):1023-8. PubMed ID: 21114924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful combination therapy of radical liver resection with 5-fluorouracil/leucovorin, oxaliplatin, plus bevacizumab for ascending colon cancer with pulmonary and 43 liver metastases: report of a case.
    Ochiai T; Masuda T; Yagi M; Kasai R; Furuyama T; Tsukamoto K; Ito H; Igari K; Aihara A; Kumagai Y; Iida M; Odajima H; Tanaka S; Arii S; Yamazaki S
    Int Surg; 2012; 97(1):6-13. PubMed ID: 23101994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Huge unresectable multiple hepatic metastases of rectum cancer responding to combined therapy with FOLFIRI +bevacizumab - a case report].
    Tagami Y; Ogata S; Katakawa M; Bando Y
    Gan To Kagaku Ryoho; 2012 Feb; 39(2):317-9. PubMed ID: 22333652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathologic complete response to neoadjuvant FOLFOX in combination with bevacizumab in unresectable metastatic colorectal carcinoma.
    Duffy A; Shia J; Huitzil-Melendez FD; Fong Y; O'Reilly EM
    Clin Colorectal Cancer; 2008 Mar; 7(2):140-3. PubMed ID: 18501074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective phase II study of neoadjuvant FOLFOX6 plus cetuximab in patients with colorectal cancer and unresectable liver-only metastasis.
    Ji JH; Park SH; Lee J; Kim TW; Hong YS; Kim KP; Kim SY; Baek JY; Kang HJ; Shin SJ; Shim BY; Park YS
    Cancer Chemother Pharmacol; 2013 Jul; 72(1):223-30. PubMed ID: 23689915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A case of synchronous multiple liver metastasis of sigmoid colon cancer with a pathological complete response to combination chemotherapy of 5-FU/LV and bevacizumab].
    Uegami S; Imamura Y; Daimaru Y; Nakamitsu A; Kouyama M; Kuwada A; Toge K; Taogoshi H; Yokoyama S; Fukuda Y
    Gan To Kagaku Ryoho; 2011 Feb; 38(2):321-4. PubMed ID: 21368505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A case of pathologically by complete response in advanced sigmoid colon cancer with multiple metastases of lung and Liver, left hydronephrosis after chemotherapy including bevacizumab/FOLFOX6].
    Kubo H; Nishiyama M; Tada K; Miyahara M; Hasegawa H; Yamashita Y
    Gan To Kagaku Ryoho; 2012 Jun; 39(6):987-9. PubMed ID: 22705699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A case of sigmoid colon cancer with peritoneal dissemination responding to third-line therapy employing bevacizumab combination therapy after failure of FOLFOX and FOLFIRI].
    Tamura T; Ishikawa N; Koui S; Nakashima H; Minagawa N; Hachiya Y; Hirata K; Sako T; Fukuyama T; Hirano Y
    Gan To Kagaku Ryoho; 2010 Sep; 37(9):1813-6. PubMed ID: 20841954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression while receiving preoperative chemotherapy should not be an absolute contraindication to liver resection for colorectal metastases.
    Viganò L; Capussotti L; Barroso E; Nuzzo G; Laurent C; Ijzermans JN; Gigot JF; Figueras J; Gruenberger T; Mirza DF; Elias D; Poston G; Letoublon C; Isoniemi H; Herrera J; Sousa FC; Pardo F; Lucidi V; Popescu I; Adam R
    Ann Surg Oncol; 2012 Sep; 19(9):2786-96. PubMed ID: 22622469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of targeted therapy with cetuximab in patients with K-ras wild-type colorectal cancer presenting with initially unresectable metastases limited to the liver in a German setting.
    Asseburg C; Frank M; Köhne CH; Hartmann JT; Griebsch I; Mohr A; Osowski U; Schulten J; Mittendorf T
    Clin Ther; 2011 Apr; 33(4):482-97. PubMed ID: 21635994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of recurrent sigmoid colon cancer with adrenal and para-aortic lymph node metastasis successfully treated by operation and chemotherapy].
    Kim HM; Ikeda M; Okano M; Miyoshi N; Hirose H; Yamashita S; Takemasa I; Mizushima T; Yamamoto H; Sekimoto M; Doki Y; Mori M
    Gan To Kagaku Ryoho; 2010 Nov; 37(12):2548-50. PubMed ID: 21224635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colorectal cancer with multiple metachronous metastasis achieving complete remission 14 years after surgical resection: report of a case.
    Murono K; Kawai K; Kazama S; Tsuno NH; Sunami E; Kitayama J; Watanabe T
    Int Surg; 2013; 98(1):49-54. PubMed ID: 23438276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A case of long-term survival due to combined modality therapy for liver metastasis of colon cancer].
    Hasegawa H; Hashimoto T; Nakamura T; Kitagawa M; Kudo K; Shoji F; Kabashima A; Teramoto S; Kitamura M
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2234-6. PubMed ID: 23268034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.